» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Name & Property Search

Name & Property Search

Search results for 'Howard Medical' | Search again
DeSoto Public Records:0
Shelby Public Records:0
Editorial:100
West Tennessee:0
Middle Tennessee:1
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

TNLedger Knoxville Edition subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. A third of US should be considering masks, officials say -

WASHINGTON (AP) — COVID-19 cases are increasing in the United States – and could get even worse over the coming months, federal health officials warned Wednesday in urging areas hardest hit to consider reissuing calls for indoor masking.

2. FDA clears COVID booster shot for healthy kids ages 5 to 11 -

U.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine dose will enhance their protection as infections once again creep upward.

Everyone 12 and older already was supposed to get one booster dose for the best protection against the newest coronavirus variants -- and some people, including those 50 and older, can choose a second booster.

3. Starbucks will cover travel for workers seeking abortions -

Starbucks said Monday it will pay the travel expenses for U.S. employees to access abortion and gender-confirmation procedures if those services aren't available within 100 milof a worker's home.

The Seattle coffee giant said it will also make the travel benefit available to the dependents of employees who are enrolled in Starbucks' health care plan. Starbucks has 240,000 U.S. employees but the company didn't say what percentage of them are enrolled in the its health care plan.

4. EXPLAINER: What's behind the baby formula shortage? -

WASHINGTON (AP) — Many parents are hunting for infant formula after a combination of short- and long-term problems hit most of the biggest U.S. brands.

Millions of babies in the U.S. rely on formula, which is the only source of nutrition recommended for infants who aren't exclusively breastfed.

5. Parents hunting for baby formula as shortage spans US -

WASHINGTON (AP) — Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading brands off store shelves.

Months of spot shortages at pharmacies and supermarkets have been exacerbated by the recall at Abbott, which was forced to shutter its largest U.S. formula manufacturing plant in February due to contamination concerns.

6. Rare cases of COVID returning pose questions for Pfizer pill -

WASHINGTON (AP) — As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.

7. Nearly 1 million COVID-19 deaths: A look at the US numbers -

Doug Lambrecht was among the first of the nearly 1 million Americans to die from COVID-19. His demographic profile — an older white male with chronic health problems — mirrors the faces of many who would be lost over the next two years.

8. FDA restricts J&J's COVID-19 vaccine due to blood clot risk -

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. U.S. authorities for months have recommended that Americans get Pfizer or Moderna shots instead of J&J's vaccine.

9. HBCU medical schools to tackle organ transplant disparities -

A new initiative aimed at increasing the number of Black Americans registered as organ donors and combating disparities among transplant recipients was announced Thursday by a coalition that includes the four medical schools at the nation's historically Black colleges and universities.

10. FDA sets June meetings on COVID vaccines for youngest kids -

WASHINGTON (AP) — The Food and Drug Administration on Friday set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children, typically the final step before authorizing the shots.

11. Racial split on COVID-19 endures as restrictions ease in US -

Black and Hispanic Americans remain far more cautious in their approach to COVID-19 than white Americans, recent polls show, reflecting diverging preferences on how to deal with the pandemic as federal, state and local restrictions fall by the wayside.

12. FDA to issue plan banning menthol in cigarettes, cigars -

WASHINGTON (AP) — The U.S. government on Thursday released its long-awaited plan to ban menthol cigarettes and flavored cigars, citing the toll on Black smokers and young people.

"The proposed rules would help prevent children from becoming the next generation of smokers and help adult smokers quit," said Health and Human Services Secretary Xavier Becerra, in a statement.

13. Moderna seeks to be 1st with COVID shots for youngest children -

Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.

14. Jones Company sold to Richmond -

Richmond American Homes of Tennessee has entered into an asset purchase agreement to acquire substantially all of the homebuilding assets of The Jones Company of Tennessee, LLC.

Jones closed over 370 homes in fiscal year 2021 in the Nashville area with an average sales price of $564,000, generating revenues of $209 million.

15. Plan to ban menthol cigarettes prompts late lobbying blitz -

WASHINGTON (AP) — As federal officials finalize a long-awaited plan to ban menthol cigarettes, dozens of interest groups have met with White House staffers to try to influence the process, which has the potential to save hundreds of thousands of lives while wiping out billions in tobacco sales.

16. Moderna announces step toward updating COVID shots for fall -

Moderna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant. On Tuesday, it reported a preliminary hint that such an approach might work.

17. E-cigs using synthetic nicotine come under FDA oversight -

WASHINGTON (AP) — U.S. regulators will soon begin cracking down on vaping companies using a now-closed loophole, including a line of fruit-flavored e-cigarettes that have become teenagers' top choice.

18. Pfizer to seek COVID booster for healthy 5- to 11-year-olds -

Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.

U.S. health authorities already urge everyone 12 and older to get one booster dose for the best protection against the newest variants -- and recently gave the option of a second booster to those 50 and older.

19. US experts discuss COVID boosters for the fall and beyond -

WASHINGTON (AP) — While many Americans are trying to move on with their lives after two years of the COVID-19 pandemic, U.S. health officials are debating the best way to use vaccines to stay ahead of the coronavirus.

20. US pulls GSK's COVID drug as omicron sibling dominates cases -

WASHINGTON (AP) — GlaxoSmithKline's IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health regulators said Tuesday.

21. FDA panel narrowly sides against experimental ALS drug -

WASHINGTON (AP) — Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

22. FDA OKs another Pfizer, Moderna COVID booster for 50 and up -

Americans 50 and older can get a second COVID-19 booster if it's been at least four months since their last vaccination, a chance at extra protection for the most vulnerable in case the coronavirus rebounds.

23. Moderna says its low-dose COVID shots work for kids younger than 6 -

Moderna's COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday -- and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.

24. FDA details problems at plant behind recalled baby formula -

WASHINGTON (AP) — Baby formula maker Abbott failed to maintain sanitary conditions and procedures at the Michigan manufacturing plant recently linked to a cluster of infant illnesses, according to findings released Tuesday by federal safety inspectors.

25. UK easing COVID-19 testing, monitoring despite case uptick -

LONDON (AP) — After dropping nearly all coronavirus restrictions last month, Britain is now ending some of its most widespread COVID-19 testing and monitoring programs, a move some scientists fear will complicate efforts to track the virus and detect worrisome new variants.

26. How will COVID end? Experts look to past epidemics for clues -

NEW YORK (AP) — Two years into the COVID-19 pandemic, most of the world has seen a dramatic improvement in infections, hospitalizations and death rates in recent weeks, signaling the crisis appears to be winding down. But how will it end? Past epidemics may provide clues.

27. EXPLAINER: Why Pfizer needs time to make COVID-19 treatment -

Pfizer's new COVID-19 treatment came with a catch when it debuted late last year: Supplies were limited, and it can take months to make the tablets.

Company leaders say they are expanding production and expect big gains in the next several months. That could help if another wave of cases develops.

28. Attorney, teacher joins GSRM Law -

The law firm of Gullett Sanford Robinson & Martin PLLC bas brought M. Clark Spoden into the firm as a partner in the firm’s litigation section.

His practice is focused on the representation of companies in contract, employment, environmental, administrative law, construction, business tort, noncompetition, intellectual property, wrongful death and personal injury cases.

29. Pregnancy-related deaths climbed in pandemic's first year -

Pregnancy-related deaths for U.S. mothers climbed higher in the pandemic's first year, continuing a decades-long trend that disproportionately affects Black people, according to a government report released Wednesday.

30. EXPLAINER: Why would world leaders balk at giving Putin DNA? -

If knowledge is power, knowing the intimate secrets of one's DNA could be a powerful weapon. That might explain why the world leaders who hastened to Moscow in recent days for diplomatic talks seemed to balk at Russian-administered coronavirus tests.

31. Senate confirms Biden's FDA pick despite political divisions -

WASHINGTON (AP) — The Senate narrowly confirmed President Joe Biden's pick to lead the Food and Drug Administration on Tuesday pushing past a thicket of political controversies that threatened to derail what was initially expected to be an easy confirmation.

32. Climate grant illustrates growth in philanthropy-funded news -

NEW YORK (AP) — The Associated Press said Tuesday that it is assigning more than two dozen journalists across the world to cover climate issues, in the news organization's largest single expansion paid for through philanthropic grants.

33. DNA analysis of elephant ivory reveals trafficking networks -

WASHINGTON (AP) — As few as three major criminal groups are responsible for smuggling the vast majority of elephant ivory tusks out of Africa, according to a new study.

Researchers used analysis of DNA from seized elephant tusks and evidence such as phone records, license plates, financial records and shipping documents to map trafficking operations across the continent and better understand who was behind the crimes. The study was published Monday in the journal Nature Human Behavior.

34. Delay ahead for Pfizer's COVID-19 vaccine for kids younger than 5 -

WASHINGTON (AP) — U.S. regulators on Friday put the brakes on their push to speed Pfizer's COVID-19 vaccine to children under 5, creating major uncertainty about how soon the shots could become available.

35. Novavax says protein vaccine works for kids as young as 12 -

Novavax announced Thursday that its COVID-19 vaccine proved safe and effective in a study of 12- to 17-year-olds.

Novavax makes a protein-based vaccine -- a different type than the most widely used shots -- that's a late arrival to the COVID-19 arsenal.

36. CDC proposes softer guidance on opioid prescriptions -

NEW YORK (AP) — The nation's top public health agency on Thursday proposed changing — and in some instances, softening — guidelines for U.S. doctors prescribing oxycodone and other opioid painkillers.

37. SpaceX satellites falling out of orbit after solar storm -

CAPE CANAVERAL, Fla. (AP) — Spacex's newest fleet of satellites is tumbling out of orbit after being struck by a solar storm.

Up to 40 of the 49 small satellites launched last week have either reentered the atmosphere and burned up, or are on the verge of doing so, the company said in an online update Tuesday night.

38. FDA's agenda in limbo as Biden's nominee stalls in Senate -

WASHINGTON (AP) — President Joe Biden's pick to lead the Food and Drug Administration has stalled in the narrowly divided Senate, an unexpected setback that could delay decisions on electronic cigarettes and a raft of other high-profile health issues pending at the agency.

39. US gives full approval to Moderna's COVID-19 vaccine -

WASHINGTON (AP) — U.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given to tens of millions of Americans since its emergency authorization over a year ago.

40. EXPLAINER: New federal law targets medical bill surprises -

Patients worried about getting hit with an unexpected bill after emergency care gained a layer of protection this month from a new federal law.

The No Surprises Act prevents doctors or hospitals in many situations from billing insured patients higher rates because the care providers are not in their insurer's coverage network.

41. Omicron amps up concerns about long COVID and its causes -

More than a year after a bout with COVID-19, Rebekah Hogan still suffers from severe brain fog, pain and fatigue that leave her unable to do her nursing job or handle household activities.

Long COVID has her questioning her worth as a wife and mother.

42. Hospital patient without COVID shot denied heart transplant -

MENDON, Mass. (AP) — A Boston hospital is defending itself after a man's family claimed he was denied a new heart for refusing to be vaccinated against COVID-19, saying most transplant programs around the country set similar requirements to improve patients' chances of survival.

43. Hope seen once the omicron wave increases global immunity -

World health officials are offering hope that the ebbing of the omicron wave could give way to a new, more manageable phase of the COVID-19 pandemic, even as they warn of difficult weeks ahead and the possibility of another, more dangerous variant arising.

44. Pfizer begins testing omicron-matched COVID shots in adults -

Pfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots.

Pfizer and its partner BioNTech announced the study on Tuesday.

45. FDA halts use of antibody drugs that don't work vs. omicron -

WASHINGTON (AP) — COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.

46. US begins offering 1B free COVID tests, but many more needed -

WASHINGTON (AP) — For the first time, people across the U.S. can log on to a government website and order free, at-home COVID-19 tests. But the White House push may do little to ease the omicron surge, and experts say Washington will have to do a lot more to fix the country's long-troubled testing system.

47. Insurers, employers start helping more with chronic disease -

Vanessa Akinniyi was stuck in denial about diabetes until a care manager from her health insurer coaxed her out.

The Jacksonville, Florida, resident didn't want to start insulin. All the medicines she tried made her sick.

48. COVID-19 pill rollout stymied by shortages as omicron rages -

WASHINGTON (AP) — Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.

49. Omicron might be headed for a rapid drop in Britain, US -

Scientists are seeing signals that COVID-19's alarming omicron wave may have peaked in Britain and is about to do the same in the U.S., at which point cases may start dropping off dramatically.

The reason: The variant has proved so wildly contagious that it may already be running out of people to infect, just a month and a half after it was first detected in South Africa.

50. Omicron surge vexes parents of children too young for shots -

Afternoons with Grammy. Birthday parties. Meeting other toddlers at the park. Parents of children too young to be vaccinated are facing difficult choices as an omicron variant-fueled surge in COVID-19 cases makes every encounter seem risky.

51. COVID case counts may be losing importance amid omicron -

The explosive increase in U.S. coronavirus case counts is raising alarm, but some experts believe the focus should instead be on COVID-19 hospital admissions. And those aren't climbing as fast.

Dr. Anthony Fauci, for one, said Sunday on ABC that with many infections causing few or no symptoms, "it is much more relevant to focus on the hospitalizations as opposed to the total number of cases." Other experts argue that case counts still have value.

52. CDC posts rationale for shorter isolation, quarantine -

NEW YORK (AP) — The Centers for Disease Control and Prevention on Tuesday explained the scientific rationale for shortening its COVID-19 isolation and quarantine recommendations, and clarified that the guidance applies to kids as well as adults.

53. How will pandemic end? Omicron clouds forecasts for endgame -

Pandemics do eventually end, even if omicron is complicating the question of when this one will. But it won't be like flipping a light switch: The world will have to learn to coexist with a virus that's not going away.

54. US adds Merck pill as 2nd easy-to-use drug against COVID-19 -

WASHINGTON (AP) — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.

The Food and Drug Administration authorization of Merck's molnupiravir comes one day after the agency cleared a competing drug from Pfizer.

55. Study: Omicron less likely to put you in the hospital -

Two new British studies provide some early hints that the omicron variant of the coronavirus may be milder than the delta version.

Scientists stress that even if the findings of these early studies hold up, any reductions in severity need to be weighed against the fact omicron spreads much faster than delta and is more able to evade vaccines. Sheer numbers of infections could still overwhelm hospitals.

56. To grandmother's house or no? Omicron disrupts holiday plans -

Dave Fravel and his wife invited several relatives to their Cape Cod home for Christmas to share food, gifts and the togetherness they've longed for during the lonely days of the pandemic. They were also looking forward to a holiday sightseeing trip to New York City.

57. Pfizer pill becomes 1st US-authorized home COVID treatment -

WASHINGTON (AP) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.

58. Monarch, GBT buy 8 acres in Midtown -

Monarch Alternative Capital LP, an investment firm with approximately $9.5 billion of assets under management, has purchased the 8-acre Beaman Toyota dealership property on Broadway.

In partnership with Nashville-based GBT Realty, Monarch plans to create a development in Midtown to address the city’s increasing real estate needs.

59. Omicron sweeps across nation, now 73% of new US COVID cases -

NEW YORK (AP) — Omicron has raced ahead of other variants and is now the dominant version of the coronavirus in the U.S., accounting for 73% of new infections last week, federal health officials said Monday.

60. Moderna: Initial booster data shows good results on omicron -

Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.

Moderna said lab tests showed the half-dose booster shot increased by 37 times the level of so-called neutralizing antibodies able to fight omicron.

61. Howard chosen as director of Tennessee Guard Joint Staff -

NASHVILLE (AP) — Brig. Gen. Cassandra Howard will be the new director of the Joint Staff for the Tennessee National Guard, Adjutant General Maj. Gen. Jeff Holmes said.

62. Pfizer study tests extra COVID vaccine dose for kids under 5 -

Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers instead of the usual two.

The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn't have as strong an immune response as expected to special low-dose shots.

63. US regulators lift in-person restrictions on abortion pill -

WASHINGTON (AP) — The Food and Drug Administration on Thursday permanently removed a major obstacle for women seeking abortion pills, eliminating a long-standing requirement that they pick up the medication in person.

64. CDC panel recommends Pfizer, Moderna vaccines over J&J shot -

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday.

The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don't come with that risk and also appear to be more effective, advisers to the Centers for Disease Control and Prevention said.

65. US faces a double coronavirus surge as omicron advances -

The new omicron coronavirus mutant speeding around the world may bring another wave of chaos, threatening to further stretch hospital workers already struggling with a surge of delta cases and upend holiday plans for the second year in a row.

66. One year of vaccines: Many lives saved, many needlessly lost -

One year ago, the biggest vaccination drive in American history began with a flush of excitement in an otherwise gloomy December. Trucks loaded with freezer-packed vials of a COVID-19 vaccine that had proved wildly successful in clinical trials fanned out across the land, bringing shots that many hoped would spell the end of the crisis.

67. Pfizer confirms COVID pill's results, potency versus omicron -

WASHINGTON (AP) — Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant.

The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms.

68. FDA expands Pfizer COVID booster, opens extra dose to age 16 -

The U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer's vaccine.

The U.S. and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the worrisome new omicron variant.

69. Vaccine makers racing to update COVID shots, just in case -

Vaccine makers are racing to update their COVID-19 shots against the newest coronavirus threat even before it's clear a change is needed, just in case.

Experts doubt today's shots will become useless but say it's critical to see how fast companies could produce a reformulated dose and prove it works -- because whatever happens with omicron, this newest mutant won't be the last.

70. Pfizer says COVID booster offers protection against omicron -

Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may protect against the new omicron variant even though the initial two doses appear significantly less effective.

Pfizer and its partner BioNTech said lab tests showed a booster dose increased by 25-fold the level of so-called neutralizing antibodies against omicron.

71. Omicron v. delta: Battle of coronavirus mutants is critical -

As the omicron coronavirus variant spreads in southern Africa and pops up in countries all around the world, scientists are anxiously watching a battle play out that could determine the future of the pandemic. Can the latest competitor to the world-dominating delta overthrow it?

72. Science report: US should make less plastic to save oceans -

America needs to rethink and reduce the way it generates plastics because so much of the material is littering the oceans and other waters, the National Academy of Sciences says in a new report.

The United States, the world's top plastics waste producer, generates more than 46 million tons (42 million metric tons) a year, and about 2.2 billion pounds (1 million metric tons) ends up in the world's oceans, according to the academy's report.

73. Panel weighs safety, effectiveness of Merck's COVID-19 pill -

WASHINGTON (AP) — Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill for patients to take at home to treat COVID-19.

74. How COVID shots for kids help prevent dangerous new variants -

LOUISVILLE, Ky. (AP) — Cadell Walker rushed to get her 9-year-old daughter Solome vaccinated against COVID-19 — not just to protect her but to help stop the coronavirus from spreading and spawning even more dangerous variants.

75. New hurdle for COVID-19 home testing -- the holiday season -

WASHINGTON (AP) — Millions more home tests for COVID-19 are hitting store shelves, but will there be enough for Americans hoping to screen themselves before holiday gatherings?

Gone are last year's long lines to get tested, thanks to nearly a year of vaccinations, increased testing supplies and quicker options. But with many Americans unvaccinated and reports of infections among those who've gotten the shots, some are looking to home tests for an extra layer of protection ahead of this year's festivities.

76. FDA official explains decision on 'simplified' booster shots -

WASHINGTON (AP) — The U.S. government's booster campaign got a lot simpler Friday after Food and Drug Administration officials authorized extra shots of Pfizer and Moderna COVID-19 vaccines for all adults.

77. US advisers support expanding COVID boosters to all adults -

WASHINGTON (AP) — The U.S. government on Friday moved to open up COVID-19 booster shots to all adults, expanding efforts to get ahead of rising coronavirus cases that experts fear could snowball into a winter surge as millions of Americans travel for the holidays.

78. US overdose deaths topped 100,000 in one year, officials say -

NEW YORK (AP) — An estimated 100,000 Americans died of drug overdoses in one year, a never-before-seen milestone that health officials say is tied to the COVID-19 pandemic and a more dangerous drug supply.

79. SpaceX's Musk: 1st Starship test flight to orbit in January -

CAPE CANAVERAL, Fla. (AP) — SpaceX founder Elon Musk said Wednesday that his company will attempt to launch its futuristic, bullet-shaped Starship to orbit in January, but he's not betting on success for that first test flight.

80. Pfizer asks US officials to OK promising COVID-19 pill -

WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.

81. Racial disparities in kids' vaccinations are hard to track -

The rollout of COVID-19 shots for elementary-age children has exposed another blind spot in the nation's efforts to address pandemic inequalities: Health systems have released little data on the racial breakdown of youth vaccinations, and community leaders fear that Black and Latino kids are falling behind.

82. Biden picks former FDA chief Califf to again lead the agency -

WASHINGTON (AP) — President Joe Biden on Friday is tapping former Food and Drug Administration commissioner Robert Califf to again lead the powerful regulatory agency, according to a person familiar with the decision.

83. 'Strong' start to kids vaccine campaign, but challenges loom -

WASHINGTON (AP) — The campaign to vaccinate elementary school age children in the U.S. is off to a strong start, health officials said Wednesday, but experts say there are signs that it will be difficult to sustain the initial momentum.

84. Pfizer asks FDA to OK COVID-19 booster shots for all adults -

Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.

85. Pfizer says COVID-19 pill cut hospital, death risk by 90% -

WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.

86. Roll up your sleeves: Kids' turn arrives for COVID-19 shots -

Hugs with friends. Birthday parties indoors. Pillow fights. Schoolchildren who got their first COVID-19 shots Wednesday said these are the pleasures they look forward to as the U.S. enters a major new phase in fighting the pandemic.

87. FDA paves way for Pfizer COVID-19 vaccinations in young kids -

WASHINGTON (AP) — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine.

The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.

88. 'Everything is at stake' as world gathers for climate talks -

More than one world leader says humanity's future, even survival, hangs in the balance when international officials meet in Scotland to try to accelerate efforts to curb climate change. Temperatures, tempers and hyperbole have all ratcheted up ahead of the United Nations summit.

89. China offers few new climate targets ahead of UN conference -

WASHINGTON (AP) — China is offering no significant new goals for reducing climate-changing emissions ahead of the UN climate summit set to start next week in Glasgow.

China, the world's top emitter of carbon dioxide and other greenhouse gasses that cause global warming, formally submitted its goals Thursday. The highly-anticipated announcement gathered targets previously established in speeches by President Xi Jinping and domestic policy documents.

90. Cheap antidepressant shows promise treating early COVID-19 -

A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.

Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.

91. Mounting money mistakes could signal dementia -

Some of the early signs of dementia are financial, forgetting to pay bills, for example, or having trouble calculating a tip. People who develop dementia also are more likely to miss credit card payments and have subprime credit scores years before they’re diagnosed, a study published last year in medical journal JAMA Internal Medicine finds.

92. FDA panel backs Pfizer's low-dose COVID-19 vaccine for kids -

WASHINGTON (AP) — The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.

93. FDA advisers review Pfizer's COVID-19 vaccine for kids -

WASHINGTON (AP) — Kid-size doses of Pfizer's COVID-19 vaccine may be getting closer as government advisers on Tuesday began deliberating whether there's enough evidence that the shots are safe and effective for 5- to 11-year-olds.

94. Moderna says its low-dose COVID shot works for kids 6 to 11 -

Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer moves toward expanding shots to children.

Competitor Pfizer's kid-sized vaccine doses are closer to widespread use, undergoing evaluation by the Food and Drug Administration for nearly the same age group — starting at age 5. Its vaccine already is authorized for anyone 12 or older.

95. EXPLAINER: Is it time to get a COVID-19 booster? Which one? -

Millions more Americans just became eligible for COVID-19 boosters, but figuring out who's eligible and when can be confusing. And adding to the challenge is that this time around, people can choose a different brand of vaccine for that extra dose.

96. COVID vaccine: CDC expands booster rollout, OKs mixing shots -

WASHINGTON (AP) — Millions more Americans can get a COVID-19 booster and choose a different company's vaccine for that next shot, federal health officials said Thursday.

Certain people who received Pfizer vaccinations months ago already are eligible for a booster and now the Centers for Disease Control and Prevention says specific Moderna and Johnson & Johnson recipients qualify, too. And in a bigger change, the agency is allowing the flexibility of "mixing and matching" that extra dose regardless of which type people received first.

97. COVID-19 vaccine: CDC panel discusses booster rollout -

WASHINGTON (AP) — Influential government advisers are deciding Thursday how best to expand the nation's COVID-19 booster campaign, including whether and when it's OK to "mix and match" brands for the extra dose.

98. US salmonella outbreak tied to onions sickens more than 650 -

NEW YORK (AP) — A salmonella outbreak tied to onions has sickened more than 650 people in 37 states, U.S. health officials said.

The Centers for Disease Control and Prevention said at least 129 people have been hospitalized. No one has died. Nearly all of the illnesses were reported in August and September, and the largest numbers of cases were in Texas and Oklahoma.

99. FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters -

WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.

100. Top Davidson County commercial sales for September 2021 -

Top commercial real estate sales, September 2021, for Davidson County, as compiled by Chandler Reports.

Chandler Reports has been publishing Real Estate Market Data since 1968. That year, Chandler began collecting residential sales information for the Chandler Residential Report, considered the authoritative source for residential real estate sales information. Over the next three decades, the publications have been continually refined, enhanced and expanded, growing to include lot sales data, new residential construction and absorption information, and commercial sales. In 1987, Chandler Reports began one of the first on–line real estate market data services in the country, and is a nationally recognized leader in the industry. In 2004, Chandler Reports was purchased by The Daily News Publishing Co. In 2007, Chandler introduced RegionPlus, including property research for Nashville and Middle Tennessee. Visit online at chandlerreports.com.